Published in World J Gastroenterol on February 21, 2005
Helicobacter pylori infection among patients with upper gastrointestinal symptoms: prevalence and relation to endoscopy diagnosis and histopathology. J Family Med Prim Care (2014) 1.02
Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study. Int J Diabetes Dev Ctries (2010) 0.96
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. World J Gastroenterol (2007) 0.84
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors. Dig Dis Sci (2008) 0.84
Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis. Dig Dis Sci (2006) 0.83
Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori. World J Gastroenterol (2010) 0.82
Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory mediator in the pathogenesis of peptic ulcer disease? Dig Dis Sci (2007) 0.82
Elevated risk for gastric adenocarcinoma can be predicted from histomorphology. World J Gastroenterol (2006) 0.81
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res (2015) 0.81
Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians. Clin Exp Med (2008) 0.80
Correlation of serum antibody titres with invasive methods for rapid detection of Helicobacter pylori infections in symptomatic children. Int J Exp Pathol (2012) 0.79
Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease. Clin Exp Immunol (2008) 0.77
Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis. World J Gastrointest Pharmacol Ther (2011) 0.75
Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico. Gut Pathog (2017) 0.75
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet (1991) 9.51
NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA (1994) 8.57
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology (1997) 3.04
Peptic-ulcer disease. Lancet (2002) 2.92
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
The antrum in patients with duodenal and gastric ulcers. Gut (1967) 2.30
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20
Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology (1972) 2.09
Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol (1989) 2.02
In diffuse atrophic gastritis, routine histology underestimates Helicobacter pylori infection. J Clin Gastroenterol (2002) 1.60
The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology (1999) 1.47
Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut (1993) 1.47
Apoptosis in different compartments of antrum and corpus mucosa in chronic Helicobacter pylori gastritis. An 18-year follow-up study. Scand J Gastroenterol (2001) 1.45
pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther (2001) 1.18
Bile reflux gastritis and intestinal metaplasia at the cardia. Gut (2002) 1.17
Helicobacter pylori. Curr Opin Infect Dis (2003) 1.16
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology (1998) 1.12
Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol (2000) 1.10
Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol (2002) 1.07
An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol (1999) 0.95
Impact of diet and smoking on risk of developing intestinal metaplasia of the stomach. Dig Dis Sci (1990) 0.94
A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep (2000) 0.92
Gastric mucosal response to Helicobacter pylori. Keio J Med (2002) 0.90
Helicobacter pylori: consensus and controversy. Clin Infect Dis (2002) 0.82
Helicobacter pylori infection and chronological extension of atrophic gastritis. Eur J Gastroenterol Hepatol (1995) 0.82
Comparison of gastric histology among Swedish and Japanese patients with peptic ulcer and Helicobacter pylori infection. Scand J Gastroenterol (2003) 0.81
[Gastric preneoplastic changes]. Recenti Prog Med (2004) 0.80
[Zollinger-Ellison syndrome]. Nihon Rinsho (2002) 0.78
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
Topography of chronic active gastritis in Helicobacter pylori-positive Asian populations: age-, gender-, and endoscopic diagnosis-matched study. J Gastroenterol (2004) 1.57
Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol (2005) 1.19
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci (2007) 1.07
Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol (2010) 1.05
Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun (2002) 1.04
Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol (2010) 1.03
Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology (2004) 1.00
Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population. BMC Microbiol (2009) 0.94
Role of metallothionein 1E in the migration and invasion of human glioma cell lines. Int J Oncol (2012) 0.94
Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B Biointerfaces (2010) 0.93
Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol (2004) 0.93
Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol (2003) 0.92
Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol (2007) 0.92
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric Cancer (2003) 0.92
Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/t-Bid mitochondrial pathway. J Asian Nat Prod Res (2012) 0.91
Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts. Dig Dis Sci (2007) 0.89
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). J Gastroenterol Hepatol (2014) 0.88
Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer. Helicobacter (2012) 0.88
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. Helicobacter (2013) 0.88
Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis (2002) 0.88
Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer (2007) 0.86
Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol (2003) 0.86
Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci (2007) 0.86
Malignant melanoma of the buttock presenting as a Buruli ulcer. J Dermatol (2002) 0.85
Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas. Acta Neurochir (Wien) (2012) 0.85
Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer. World J Gastroenterol (2013) 0.84
Evaluation of rapid urine test for the detection of Helicobacter pylori infection in the Vietnamese population. Dig Dis Sci (2009) 0.83
Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping. Clin Vaccine Immunol (2009) 0.83
[Clinical significance of a standardized clinical pathway in gastrectomy patients]. J Nippon Med Sch (2003) 0.82
Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. World J Gastroenterol (2005) 0.82
Comparison between the 13C-urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. J Gastroenterol (2004) 0.81
Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. FEMS Immunol Med Microbiol (2005) 0.81
Unusual petal-like fibromuscular dysplasia as a cause of acute abdomen and circulatory shock. Jpn Heart J (2002) 0.81
Simple and accurate (13)C-urea breath test for detection of Helicobacter pylori in the remnant stomach after surgery. J Gastroenterol (2006) 0.81
Expression of E-cadherin catenin and C-erbB-2 gene products in invasive ductal-type breast carcinomas. J Nippon Med Sch (2002) 0.81
Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection. J Gastroenterol (2004) 0.80
[Surgical treatment of gastric remnant-stump cancer]. J Nippon Med Sch (2002) 0.80
Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World J Gastroenterol (2008) 0.80
Successful endoscopic sclerotherapy for bleeding gastric varices with combined cyanoacrylate and aethoxysklerol. World J Gastroenterol (2008) 0.80
Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach. J Gastroenterol Hepatol (2008) 0.79
Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtype. World J Gastroenterol (2005) 0.79
Helicobacter pylori Infection among patients visiting a clinic in Kasama City, Ibaraki Prefecture. J Nippon Med Sch (2005) 0.79
Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells. Dig Dis Sci (2008) 0.79
Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines. Helicobacter (2004) 0.78
Endoscopic features predictive of gastric cancer in superficial lesions with biopsy-proven high grade intraepithelial neoplasia. World J Gastroenterol (2009) 0.77
Branched polyethylenimine improves hydrogen photoproduction from a CdSe quantum dot/[FeFe]-hydrogenase mimic system in neutral aqueous solutions. Chemistry (2015) 0.77
Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry. Int J Lepr Other Mycobact Dis (2002) 0.77
Amphiphilic polymeric micelles as microreactors: improving the photocatalytic hydrogen production of the [FeFe]-hydrogenase mimic in water. Chem Commun (Camb) (2015) 0.77
Delivery of Transferrin-Conjugated Polysaccharide Nanoparticles in 9L Gliosacoma Cells. J Nanosci Nanotechnol (2015) 0.77
Release of tissue inhibitor of metalloproteinase-2 from alginate microcapsule encapsulating genetically engineered cells. Int J Nanomedicine (2013) 0.77
Ultrastructural changes and immunohistochemical localization of advanced glycation end products in the heart of streptozotocin-treated Mongolian gerbils. Med Electron Microsc (1999) 0.77
Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats. World J Gastroenterol (2003) 0.76
Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination. World J Gastroenterol (2000) 0.75
[Responses of soybean to O3, CO2 and their combination]. Ying Yong Sheng Tai Xue Bao (2005) 0.75
Gastroduodenal pathology in patients with asymptomatic gallbladder stones. Hepatogastroenterology (2014) 0.75
[The present status of nutritional therapy after gastrectomy according to the commentary for the guideline of gastric cancer therapy]. J Nippon Med Sch (2003) 0.75
[An economic evaluation on the clinical pathway for gastrectomy]. Nihon Shokakibyo Gakkai Zasshi (2003) 0.75
Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach. Surg Today (2005) 0.75
Modified toluidine blue: an alternative stain for Helicobacter pylori detection in routine diagnostic use and post-eradication confirmation for gastric cancer prevention. Asian Pac J Cancer Prev (2014) 0.75
Phenolyc glycolipid-1 found in tissues infected by Mycobacterium ulcerans. J Dermatol (2002) 0.75
Buruli and the ulcers under the tropics. Am J Dermatopathol (2002) 0.75
[Effects of double CO2 and O3 on growth and yields in soybean]. Huan Jing Ke Xue (2004) 0.75
[Clinical usefulness of the percutaneous trans esophageal gastro-tubing (PTEG) for decompression of the bowels and for transintestinal nutrition]. J Nippon Med Sch (2002) 0.75
[Enzymatic production of oral nutritional liquid from oyster]. Zhong Yao Cai (2010) 0.75